Wednesday, January 28, 2026
3:00–4:00 PM ET | (45-minute discussion + 15-minute Q&A)
Live Webinar + Q&A
Virtual Event | Free to Attend
Overview
On December 18, 2025, President Trump signed an Executive Order directing federal agencies to evaluate and pursue the rescheduling of cannabis from Schedule I to Schedule III. This represents a significant turning point for the cannabis industry and those serving it, particularly financial institutions. While rescheduling is not legalization, it carries profound implications for business planning, regulatory compliance, and market opportunities.
For cannabis businesses and the financial institutions supporting them, rescheduling will reshape the competitive landscape, risk assessments, and access to capital. This session will provide practical, strategic guidance on what’s changing, what isn’t, and how businesses should be preparing now.
Join Bob Hoban, Co-Founder and Chairman of CTrust and one of the most recognized voices in cannabis law and regulation, and Cogent Law Partners Suehiko Ono and Chris Van Dyck for an in-depth exploration of what rescheduling means in practice. This session will equip you with the insights and frameworks you need to navigate the evolving cannabis landscape with confidence.
Who Should Attend
- Financial institution executives, strategy leaders, and business development teams evaluating launching, or expanding cannabis banking and payments programs
- Compliance, BSA/AML, regulatory, and risk management professionals responsible for cannabis banking programs within banks and financial institutions
- Board members and senior leadership of financial institutions overseeing governance, risk, and strategic decisions related to cannabis banking initiatives
- Cannabis industry consultants and advisors
- Investors and stakeholders in cannabis enterprises
What You’ll Learn
- Parsing Trump’s Executive Order: Understanding the directive, its scope, and implications
- How the rescheduling process may unfold, including potential delays and regulatory hurdles
- What being a Schedule III substance means and the functional differences and operational implications compared to Schedule I
- How federal rescheduling may interact with state-level cannabis regulations and
licensing frameworks - Planning considerations for cannabis businesses
- Strategic and operational steps financial institutions should take now to prepare
- New compliance frameworks and revenue opportunities
- Updates regarding the Infused Hemp product market
Meet the Speakers
Bob Hoban
Co-Founder & Chairman, CTrust
Bob Hoban is an accomplished legal and business professional with extensive experience in cannabis law, finance, and international regulation. He has overseen $1B+ in financial transactions and provided regulatory counsel to more than 30 states and international governments. Bob frequently lectures worldwide and has been featured in outlets such as Forbes and CNN.
His unique combination of regulatory expertise and business leadership makes him one of the most sought-after advisors in the cannabis industry. In addition to his advisory work, Bob serves as Co-Founder and Chairman of CTrust.
Suehiko Ono
Partner, Cogent Law
Suehiko Ono is a cannabis industry attorney, entrepreneur, and operator with deep experience in licensing, compliance, and commercial transactions in highly regulated markets. He founded and scaled EOS Farms, one of Maine’ first licensed outdoor cultivation facilities, and later held senior legal and operational roles with a leading New York adult-use cultivator.
Combining legal training and hands-on operating experience, he advises cannabis founders, investors, and operators on governance, financing, brand licensing, and risk management, helping them build resilient, sustainable businesses.
Chris Van Dyck
Partner, Cogent Law
As a Partner at Cogent Law, Chris Van Dyck brings over a decade of hands-on experience in cannabis banking, both as a financial regulatory attorney and as a general counsel and BSA officer at a financial institution. With a deep understanding of compliance and regulatory expectations, including the 2014 FinCEN guidance, Chris has helped build and scale a successful cannabis banking program that became a major revenue driver.
Today, he advises financial institutions on launching and managing compliant cannabis banking programs, mitigating risk, and driving growth in this high-opportunity sector.
Event Details
Date: Wednesday, January 28, 2026
Time: 3:00–4:00 PM ET (45-minute discussion + 15-minute Q&A)
Location: Virtual Event
Cost: Free to Attend